There may be efforts in their research pipeline to address the issue of potential dangers of visible bubbles in their injector syringes and the resulting delay in angiogram procedures. However, potential competitors are major auto-injector companies such as GE Healthcare, Bayer, and Bracco. There are no comparable devices that aim to transport sterile fluids in a quick, safe, simple, and cost-effective manner. Additional Revenue with Bubble Trouble Competitive Advantage Bubbles formed using the current method are bigger and more variable in size.įigure 14. Variances between two groups are not equal (p<0.0001, F-Ratio = 13.7149). (Figure 12).ĭiameter of bubbles measured using ImageJ, analyzed distribution using F-test (JMP, Prism).
A MESS O TROUBLE BUBBLE TRIAL
The number of bubbles emerging in each trial has decreased by two-fold. There is a 58% decrease in the quantity of bubbles and 25% decrease in the bubble diameter. Results from 6 trials showed that there was a statistically significant decrease in bubble size and quantity with our device (p<0.05). The images for baseline analysis were provided by our IR technician collaborators. The baseline for comparison was the bubbles observed in the injector syringes filled using current practice. We used the same set-up as test #1 but analyzed the observed bubbles using ImageJ. One of the design specifications of our device was that it had to significantly decrease the size and volume of air bubbles in the injector syringe. The second test focused on examining the functionality of our device. Test #2: Improvement in Functionality (Decrease in Bubble Size)
It also describes one of the possible directions we may take in the future, which is to add a sensor to improve the automation and functionality of our system Figure 6.įigure 11. The process for users to utilize our device is outlined in Figure 2.īelow is an animation that describes the concept behind the device. This allows the technician to perform other key tasks to speed up the clinical workflow. With just one click, our device fills the syringes used in angiograms faster, safer and more reliably. The bubble removal process is comprised of a pump, tubing and our novel Bubble Stopper, utilizing positive pressure to deliver contrast agents to the injector syringe. Jonathan Stone URMC Neurosurgeon Our Product: Bubble Stopper There have been cases where patients died or experienced a stroke.” “Bubbles are definitely bad for the patient’s well-being. Any possible action must be made to mitigate bubbles.” I cannot agree more that there are catastrophic circumstances if the bubbles were to be neglected. They all are nervous and cautious when preparing for angiogram procedures. Surgeons and other clinicians are all aware of the problem. “It is a huge concern bubbles may lead to air embolisms or in some cases a stroke. We have received feedback from over fifteen subject matter experts regarding the clinical need, usability and other considerations for our device. We have had the opportunity to pitch our idea and product to several neurosurgeons, medical students, leading medical device sales representatives, OR technicians and residents. Our technology has the potential to be the new standard of care in any procedure requiring fluids to be injected into patients such as for hemodialysis, angiograms, MRIs and infusions. The decreased need for contrast agent preparation will lead to a decrease in surgical time and improved patient care, resulting in an additional $3.6 million in annual revenue per operating room. Its fully automated design enables clinicians to focus on more demanding tasks and provide better care to patients.
A MESS O TROUBLE BUBBLE FREE
Bubble Trouble’s novel technology, Bubble Stopper, efficiently transports sterile fluids to aid clinicians in preparing contrast agent free from dangerous bubbles twice as fast compared to current practice. Abstractīubble Trouble seeks to improve patient quality of care and operating room turnover. Reach us with wholehearted passion, trust and a strong foundation, our team is eager to apply our biomedical engineering background to the clinical field to make a positive impact within the healthcare system. Bubble Trouble Mission Statement The Team Bubble Trouble is the industry’s first and only medical device company that aims to eliminate bubbles in all surgical procedures to aid healthcare professionals prepare contrast agents faster, safer and simpler.
0 kommentar(er)
